MASATAKA SUZUKI to Receptors, Immunologic
This is a "connection" page, showing publications MASATAKA SUZUKI has written about Receptors, Immunologic.
Connection Strength
0.052
-
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy. Cancer Res. 2023 12 15; 83(24):4047-4062.
Score: 0.052